Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy


Buyuksimsek M., Ogul A., Mirilli C., PAYDAŞ S.

EUROPEAN JOURNAL OF BREAST HEALTH, cilt.16, ss.229-234, 2020 (ESCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 16 Konu: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.5152/ejbh.2020.5556
  • Dergi Adı: EUROPEAN JOURNAL OF BREAST HEALTH
  • Sayfa Sayıları: ss.229-234

Özet

Objective: Response to neoadjuvant chemotherapy (NAC) is predictive for survival times in some patients with breast cancer (BC). The aim of this study is to explore the predictive value of some inflammatory markers including neutrophil-to-lymphocyte ratio (NLR), derived neutrophilto-lymphocyte ratio (dNLR), monocyte-to-high density lipoprotein ratio (MHR) and prognostic nutritional index (PNI) in cases with BC treated with NAC.